IDMPS will be an international, multicenter, observational study with a cross-sectional study to assess current practices in the management in the patients with type 1 and type 2 diabetes mellitus non-interventional on therapeutic strategy
Phase 4
Completed
- Conditions
- Health Condition 1: null- Type 1 and Type 2 Diabetes MellitusHealth Condition 2: E109- Type 1 diabetes mellitus without complications
- Registration Number
- CTRI/2012/02/002407
- Lead Sponsor
- Sanofi Synthelabo I Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 12519
Inclusion Criteria
1. All male and female adult patients (who have attained majority) diagnosed with type 1 and type 2 DM ,visiting physician during the recruitment period of the cross-sectional study, up to the number of patients allocated to the physician.
2. Written Informed Consent
Exclusion Criteria
1. Concomitant participation to a clinical trial
2. Previous participation in this study
3. Current temporary insulin therapy (gestational diabetes, surgery, pancreas cancer)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Objective: To assess the therapeutic management of type 2 diabetic patients in the current medical practice.Timepoint: This is observational study. The outcome will be assessed at the time of statistical analysis, planned in Q4 2012
- Secondary Outcome Measures
Name Time Method 1. To assess the therapeutic management of type 1 diabetic patients in the current medical practice. <br/ ><br> <br/ ><br>2. To assess the proportion of patients under the HbA1c threshold compared to the international recommendations. <br/ ><br>Timepoint: This is observational study. The outcome will be assessed at the time of statistical analysis, planned in Q4 2012